Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 25.45 -2.12% -0.55
ODT closed down 2.12 percent on Tuesday, June 19, 2018, on 1.15 times normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical ODT trend table...

Date Alert Name Type % Chg
Jun 19 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jun 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jun 19 Outside Day Range Expansion 0.00%
Jun 18 MACD Bearish Signal Line Cross Bearish -2.12%
Jun 18 1,2,3 Pullback Bullish Bullish Swing Setup -2.12%
Jun 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.12%
Jun 15 1,2,3 Pullback Bullish Bullish Swing Setup -4.03%
Jun 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.03%
Jun 15 Doji - Bullish? Reversal -4.03%
Jun 14 1,2,3 Pullback Bullish Bullish Swing Setup -3.96%

Older signals for ODT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2018-05-09
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 8 Play the Best Sector of Summer With These ETFs & Stocks
Jun 6 Can The Uptrend Continue for Odonate Therapeutics (ODT)?
Jun 5 New Research: Key Drivers of Growth for Helen of Troy, Macro Bank, American Software, Shire plc, KB Financial Group, and Odonate Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
Jun 4 The Week Ahead: Apple's Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs
Jun 2 Tesetaxel, Administered Orally as a Single Agent, Results in 45% Confirmed Response Rate in Patients with HER2 Negative, Hormone Receptor Positive, Metastatic Breast Cancer
Jun 2 Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C.
May 31 Odonate Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
May 16 Odonate Therapeutics Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 3 Odonate Therapeutics beats by $0.18
May 3 Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2018
See more ODT news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 15.15
Average Volume 40,769
200-Day Moving Average 0.0
50-Day Moving Average 23.4095
20-Day Moving Average 25.4868
10-Day Moving Average 26.758
Average True Range 1.2644
ADX 33.8
+DI 21.13
-DI 17.34
Chandelier Exit (Long, 3 ATRs ) 24.7768
Chandelier Exit (Short, 3 ATRs ) 26.0332
Upper Bollinger Band 28.7276
Lower Bollinger Band 22.246
Percent B (%b) 0.49
BandWidth 25.431204
MACD Line 0.8736
MACD Signal Line 1.0194
MACD Histogram -0.1458
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.47
Resistance 3 (R3) 28.62 27.77 27.96
Resistance 2 (R2) 27.77 27.00 27.69 27.79
Resistance 1 (R1) 26.61 26.53 26.19 26.46 27.63
Pivot Point 25.76 25.76 25.55 25.68 25.76
Support 1 (S1) 24.60 24.99 24.18 24.45 23.27
Support 2 (S2) 23.75 24.52 23.67 23.11
Support 3 (S3) 22.59 23.75 22.94
Support 4 (S4) 22.44